Table 3

Meta-analysis of type-specific HPV DNA prevalence in invasive cervical cancer [15], updated with 63 newly published studies by Clifford (IARC)

N tested

N pos

% pos

95% CI


hpv39

13370

172

1.29

1.10 – 1.48

hpv59

13471

172

1.28

1.09 – 1.47

hpv51

13057

151

1.16

0.97 – 1.34

hpv56

13247

103

0.78

0.63 – 0.93

hpv68

11982

73

0.61

0.47 – 0.75

hpv73

9939

48

0.48

0.35 – 0.62

hpv6

14912

68

0.45

0.35 – 0.56

hpv53

8140

34

0.42

0.28 – 0.56

hpv66

12118

47

0.39

0.28 – 0.50

hpv70

10503

35

0.33

0.22 – 0.44

hpv82

9265

25

0.27

0.16 – 0.38

hpv26

6111

8

0.13

0.04 – 0.22


HPV types 30, 34, 67, 85 and 97 were not studied in the meta-analysis dataset.

Schiffman et al. Infectious Agents and Cancer 2009 4:8   doi:10.1186/1750-9378-4-8

Open Data